<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:55:59Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4364870" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4364870</identifier><datestamp>2016-03-01</datestamp><setSpec>emborep</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">EMBO Rep</journal-id>
      <journal-id journal-id-type="iso-abbrev">EMBO Rep</journal-id>
      <journal-id journal-id-type="publisher-id">embr</journal-id>
      <journal-title-group>
        <journal-title>EMBO Reports</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1469-221X</issn>
      <issn pub-type="epub">1469-3178</issn>
      <publisher>
        <publisher-name>BlackWell Publishing Ltd</publisher-name>
        <publisher-loc>Oxford, UK</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4364870</article-id>
      <article-id pub-id-type="pmcid">PMC4364870</article-id>
      <article-id pub-id-type="pmc-uid">4364870</article-id>
      <article-id pub-id-type="pmid">25608530</article-id>
      <article-id pub-id-type="pmid">25608530</article-id>
      <article-id pub-id-type="doi">10.15252/embr.201439151</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Scientific Reports</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Plasticity of PI4KIIIÎ± interactions at the plasma membrane</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Chung</surname>
            <given-names>Jeeyun</given-names>
          </name>
          <xref ref-type="aff" rid="au1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nakatsu</surname>
            <given-names>Fubito</given-names>
          </name>
          <xref ref-type="aff" rid="au1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baskin</surname>
            <given-names>Jeremy M</given-names>
          </name>
          <xref ref-type="aff" rid="au1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>De Camilli</surname>
            <given-names>Pietro</given-names>
          </name>
          <xref ref-type="aff" rid="au1"/>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
        <aff id="au1">
          <institution>Department of Cell Biology, Howard Hughes Medical Institute, Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University Medical School</institution>
          <addr-line>New Haven, CT, USA</addr-line>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">
* Corresponding author. Tel: +1 203 737 4461; E-mail: <email>pietro.decamilli@yale.edu</email></corresp>
        <fn>
          <p><bold>Subject Categories</bold> Membrane &amp; Intracellular Transport</p>
        </fn>
        <fn>
          <p>[The copyright line of this article was changed on 4 March 2015 after original online publication.]</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>1</month>
        <year>2015</year>
      </pub-date>
      <volume>16</volume>
      <issue>3</issue>
      <fpage>312</fpage>
      <lpage>320</lpage>
      <history>
        <date date-type="received">
          <day>11</day>
          <month>6</month>
          <year>2014</year>
        </date>
        <date date-type="rev-recd">
          <day>17</day>
          <month>12</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>12</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2015 The Authors</copyright-statement>
        <copyright-year>2015</copyright-year>
      </permissions>
      <abstract>
        <p>Plasma membrane PI4P is an important direct regulator of many processes that occur at the plasma membrane and also a biosynthetic precursor of PI(4,5)P<sub>2</sub> and its downstream metabolites. The majority of this PI4P pool is synthesized by an evolutionarily conserved complex, which has as its core the PI 4-kinase PI4KIIIÎ± (Stt4 in yeast) and also comprises TTC7 (Ypp1 in yeast) and the peripheral plasma membrane protein EFR3. While EFR3 has been implicated in the recruitment of PI4KIIIÎ± via TTC7, the plasma membrane protein Sfk1 was also shown to participate in this targeting and activity in yeast. Here, we identify a member of the TMEM150 family as a functional homologue of Sfk1 in mammalian cells and demonstrate a role for this protein in the homeostatic regulation of PI(4,5)P<sub>2</sub> at the plasma membrane. We also show that the presence of TMEM150A strongly reduces the association of TTC7 with the EFR3-PI4KIIIÎ± complex, without impairing the localization of PI4KIIIÎ± at the plasma membrane. Collectively our results suggest a plasticity of the molecular interactions that control PI4KIIIÎ± localization and function.</p>
      </abstract>
      <kwd-group>
        <kwd>phospholipase C</kwd>
        <kwd>PI4KA</kwd>
        <kwd>Rolling blackout</kwd>
        <kwd>Ypp1</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Phosphoinositides are phospholipids derived from the phosphorylation of phosphatidylinositol at the 3-, 4- and 5-positions of the inositol ring <xref rid="b1" ref-type="bibr">1</xref>, <xref rid="b2" ref-type="bibr">2</xref>. The seven phosphoinositides are differentially localized on the cytosolic leaflets of cellular membranes, where they play a critical role in controlling interactions that occur at their surface. Via this mechanism, which helps generate a code of membrane identity, they regulate a multiplicity of cellular processes <xref rid="b1" ref-type="bibr">1</xref>, <xref rid="b2" ref-type="bibr">2</xref>. Among phosphoinositides, phosphatidylinositol 4-phosphate (PI4P) plays numerous fundamental roles in the Golgi complex, the endosomal system, and the plasma membrane <xref rid="b1" ref-type="bibr">1</xref>, <xref rid="b2" ref-type="bibr">2</xref>, <xref rid="b3" ref-type="bibr">3</xref>.</p>
      <p>PI4P is a biosynthetic precursor of PI(4,5)P<sub>2</sub> and thus an upstream metabolite in metabolic pathways leading to diacylglycerol (DAG), IP<sub>3</sub>, and PI(3,4,5)P<sub>3</sub>
<xref rid="b4" ref-type="bibr">4</xref>. In addition, PI4P can contribute to the regulation of other membrane lipids, including sterols <xref rid="b5" ref-type="bibr">5</xref>, <xref rid="b6" ref-type="bibr">6</xref>, <xref rid="b7" ref-type="bibr">7</xref>, <xref rid="b8" ref-type="bibr">8</xref>, phosphatidylserine <xref rid="b9" ref-type="bibr">9</xref>, and sphingolipids <xref rid="b10" ref-type="bibr">10</xref>. Therefore, tight regulation of PI4P levels is important for a variety of cellular functions.</p>
      <p>In mammals, four enzymes can phosphorylate phosphatidylinositol at the 4-position of the inositol ring to generate PI4P <xref rid="b2" ref-type="bibr">2</xref>, <xref rid="b3" ref-type="bibr">3</xref>. Of the four enzymes, PI 4-kinase type IIIÎ± (PI4KIIIÎ±; Stt4 in yeast) plays a major role in the generation of PI4P at the plasma membrane <xref rid="b11" ref-type="bibr">11</xref>, <xref rid="b12" ref-type="bibr">12</xref>, <xref rid="b13" ref-type="bibr">13</xref>, <xref rid="b14" ref-type="bibr">14</xref>. This enzyme is of fundamental physiological importance, as germline disruption of its gene in mice produces embryonic lethality, and its conditional disruption in mouse fibroblasts results in cell death <xref rid="b11" ref-type="bibr">11</xref>, <xref rid="b15" ref-type="bibr">15</xref>, <xref rid="b16" ref-type="bibr">16</xref>. Interest in this enzyme has been recently enhanced by its identification as a critical host factor for the replication of the hepatitis C virus in humans <xref rid="b17" ref-type="bibr">17</xref>, <xref rid="b18" ref-type="bibr">18</xref>, <xref rid="b19" ref-type="bibr">19</xref>.</p>
      <p>PI4KIIIÎ±/Stt4 localizes to the plasma membrane as part of an evolutionarily conserved complex comprising two adaptor proteins (each of them represented by two similar A and B isoforms), the peripheral membrane protein EFR3 and the scaffolding protein TTC7 (Ypp1 in yeast) <xref rid="b11" ref-type="bibr">11</xref>, <xref rid="b12" ref-type="bibr">12</xref>, <xref rid="b20" ref-type="bibr">20</xref>. Studies in yeast have identified an additional regulator of Stt4, termed Sfk1 (suppressor of four-kinase 1), a multipass transmembrane protein localized at the plasma membrane, whose overexpression partially rescues defects in a temperature-sensitive Stt4 mutant strain <xref rid="b21" ref-type="bibr">21</xref>. Sfk1 physically interacts with Stt4, and loss of Sfk1 compromises proper plasma membrane localization of Stt4 <xref rid="b21" ref-type="bibr">21</xref>. Despite the importance of Sfk1 in the regulation of Stt4 localization and function in yeast, no mammalian counterpart of Sfk1 has yet been reported, and major outstanding questions remain about how the PI4KIIIÎ± complex is regulated at the plasma membrane. Here, we identify TMEM150A as a mammalian homologue of yeast Sfk1. TMEM150A forms a complex at the plasma membrane with PI4KIIIÎ± and EFR3, but not TTC7, suggesting a plasticity of the protein interactions of PI4KIIIÎ±. We also find that levels of TMEM150A impact the rate of PI(4,5)P<sub>2</sub> re-synthesis following acute depletion of this lipid, possibly due to an impact of this protein on the pool of PI4P available for the synthesis of PI(4,5)P<sub>2</sub>.</p>
    </sec>
    <sec>
      <title>Results and Discussion</title>
      <sec>
        <title>Putative identification of TMEM150A as a mammalian homologue of yeast Sfk1</title>
        <p>BLAST searches for amino acid sequences in higher eukaryotes related to regions of Sfk1 highly conserved among various species of yeast and fungi yielded members of the mammalian TMEM150/FRAG1/DRAM family, whose defining structural feature is the presence of six predicted transmembrane regions (Fig<xref ref-type="fig" rid="fig01">1A</xref>). DRAM (Damage-Regulated Autophagy Regulator) 1 and 2 were reported to be localized in lysosomal membranes and to function as p53-induced modulators of autophagy <xref rid="b22" ref-type="bibr">22</xref>, <xref rid="b23" ref-type="bibr">23</xref>. TMEM150A, TMEM150B, and TMEM150C remain uncharacterized. Thus, we explored whether TMEM150A proteins could be functional homologues of yeast Sfk1 in the control of the localization and function of PI4KIIIÎ±, the mammalian homologue of yeast Stt4 <xref rid="b21" ref-type="bibr">21</xref>.</p>
        <fig id="fig01" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Identification of a mammalian homologue of yeast Sfk1
<list list-type="simple"><list-item><p>A Domain cartoons of yeast Sfk1 and of its putative homologues in mammals. The light gray portions represent FRAG1/DRAM/Sfk1 family homology and the superimposed darker boxes represent transmembrane domain regions.</p></list-item><list-item><p>B Confocal imaging of live HeLa cells transfected with TMEM150A-GFP, TMEM150B-GFP, and TMEM150C-GFP as indicated. Scale bars: 20Â Î¼m.</p></list-item><list-item><p>C Western blot analysis for GFP and PI4KIIIÎ± of anti-GFP immunoprecipitates from lysates of HeLa cells transfected with GFP or TMEM150A-GFP fusion proteins.</p></list-item></list></p>
          </caption>
          <graphic xlink:href="embr0016-0312-f1"/>
        </fig>
        <p>C-terminally GFP-tagged TMEM150A, TMEM150B, or TMEM150C were transiently expressed in HeLa cells. TMEM150A-GFP and TMEM150B-GFP were predominantly localized at the plasma membrane, and only a minor pool of these proteins was localized on intracellular structures. TMEM150C-GFP was localized at the plasma membrane, but a greater pool of this protein was localized on intracellular vesicular structures (Fig<xref ref-type="fig" rid="fig01">1B</xref>) that co-localized with RFP-tagged LAMP1 (a lysosomal marker) (SupplementaryÂ <xref ref-type="supplementary-material" rid="sd1">Fig S1</xref>). Western blot analysis of anti-GFP immunoprecipitates generated from these cells, and from cells expressing GFP alone as a control, revealed coprecipitation of PI4KIIIÎ± with TMEM150A, although not B or C (Fig<xref ref-type="fig" rid="fig01">1C</xref>). Based on these results, we further explored the properties of TMEM150A and its potential function in PI4KIIIÎ± regulation.</p>
      </sec>
      <sec>
        <title>TMEM150A interacts with PI4KIIIÎ± via its C-terminal cytoplasmic region</title>
        <p>To determine the topology of TMEM150A within the plasma membrane, live HeLa cells expressing TMEM150A-GFP were exposed to an anti-GFP antibody at 4Â°C without permeabilization by detergent. While intrinsic GFP fluorescence was observed, anti-GFP immunostaining did not give any signal without prior fixation and permeabilization (Fig<xref ref-type="fig" rid="fig02">2A</xref>, upper panel), indicating that the C-terminal tail of TMEM150A is oriented toward the cytosol. By contrast, immunofluorescence analysis of a construct containing an HA tag in the middle of Loop 1 (termed HA-TMEM150A-GFP) produced fluorescence without any prior permeabilization, suggesting that Loop 1 is exposed to the extracellular medium (Fig<xref ref-type="fig" rid="fig02">2A</xref>, bottom panel). Based on these results, we hypothesized that TMEM150A has the topology illustrated in Fig<xref ref-type="fig" rid="fig02">2B</xref>, with a C-terminal cytosolic tail.</p>
        <fig id="fig02" position="float">
          <label>Figure 2</label>
          <caption>
            <p>TMEM150A interacts with the PI4KIIIÎ± complex via its C-terminal tail
<list list-type="simple"><list-item><p>A Fluorescence of HeLa cells expressing TMEM150A-GFP (top) or HA-TMEM150A-GFP (bottom) (see cartoons at left) and incubated with anti-GFP (top) or anti-HA (bottom) antibodies without permeabilization before fixation. Left panels represent intrinsic GFP fluorescence, and right panels represent anti-GFP or anti-HA immunofluorescence.</p></list-item><list-item><p>B Schematic diagram of TMEM150A, TMEM150B, and Chimera. Chimera was generated by fusing the C-terminal 40 amino acids of TMEM150A (dotted box) to the C-terminus of full-length TMEM150B.</p></list-item><list-item><p>C Snapshot of confocal live imaging of HeLa cell expressing Chimera-GFP. Scale bar: 20Â Î¼m.</p></list-item><list-item><p>D Anti-FLAG and anti-GFP Western blots of immunoprecipitates generated from lysates of HeLa cells double-transfected with 3Â ÃÂ FLAG-PI4KIIIÎ± and either TMEM150A-GFP, TMEM150B-GFP, or Chimera-GFP.</p></list-item></list></p>
          </caption>
          <graphic xlink:href="embr0016-0312-f2"/>
        </fig>
        <p>Next, we determined the region of TMEM150A responsible for the recovery of a pool of PI4KIIIÎ± in anti-TMEM150A-GFP immunoprecipitates. The C-tail is the major portion of TMEM150A protruding toward the cytosol. Thus, we focused on this region. Because TMEM150B-GFP does not coprecipitate PI4KIIIÎ±, we generated a chimeric protein (Chimera) in which the C-tail of TMEM150A was appended to the C-terminus of full-length TMEM150B (Fig<xref ref-type="fig" rid="fig02">2B</xref>). This Chimera was targeted to the plasma membrane, similar to both TMEM150A-GFP and TMEM150B-GFP, indicating that its longer C-tail did not affect its subcellular targeting (Fig<xref ref-type="fig" rid="fig02">2C</xref>). Anti-GFP immunoprecipitation experiments were then performed in cells coexpressing 3Â ÃÂ FLAG-PI4KIIIÎ± and either TMEM150A-GFP, TMEM150B-GFP, or Chimera-GFP. As shown in Fig<xref ref-type="fig" rid="fig02">2D</xref>, anti-FLAG Western blotting revealed that PI4KIIIÎ± coprecipitated to the same extent with either TMEM150A or with Chimera, while it did not coprecipitate with TMEM150B. We conclude that the portion of TMEM150A required for the formation of a complex with PI4KIIIÎ± possibly indirectly is its cytosolic C-tail.</p>
      </sec>
      <sec>
        <title>TMEM150A alone is not sufficient to recruit PI4KIIIÎ± to the plasma membrane</title>
        <p>We previously reported that PI4KIIIÎ± forms a complex with EFR3B and TTC7B at the plasma membrane <xref rid="b11" ref-type="bibr">11</xref> and that both EFR3B and TTC7B are required for PI4KIIIÎ± targeting to the plasma membrane (Supplementary <xref ref-type="supplementary-material" rid="sd1">Fig S2</xref>) <xref rid="b11" ref-type="bibr">11</xref>, <xref rid="b12" ref-type="bibr">12</xref>, <xref rid="b20" ref-type="bibr">20</xref>: EFR3 is the plasma membrane-anchored component <xref rid="b11" ref-type="bibr">11</xref>, <xref rid="b20" ref-type="bibr">20</xref>, while PI4KIIIÎ± is recruited to EFR3 indirectly by TTC7 (see <xref ref-type="fig" rid="fig05">5</xref>Fig F) <xref rid="b11" ref-type="bibr">11</xref>, <xref rid="b20" ref-type="bibr">20</xref>. In view of the recovery of a pool endogenous PI4KIIIÎ± in anti-TMEM150A-GFP immunoprecipitates, as described above, we explored whether overexpression of TMEM150A in HeLa cells could bypass the need for EFR3 and TTC7 in the plasma membrane recruitment of PI4KIIIÎ±. As shown by Fig<xref ref-type="fig" rid="fig03">3A</xref>, this was not the case, as GFP-PI4KIIIÎ± had a diffuse cytosolic distribution in cells expressing TMEM150A-mCherry, which was localized in the plasma membrane. This discrepancy between the two localizations is consistent with the low recovery of PI4KIIIÎ± in anti-TMEM150A-GFP immunoprecipitates, in spite of the specificity of this recovery (Fig<xref ref-type="fig" rid="fig03">3B</xref>). Co-overexpression of tagged PI4KIIIÎ±, EFR3B, TTC7B, and TMEM150A in different combinations revealed that plasma membrane targeting of PI4KIIIÎ± occurred only when both TTC7 and EFR3 were also co-overexpressed (Fig<xref ref-type="fig" rid="fig03">3A</xref>). Thus, even in the presence of co-overexpressed TMEM150A, efficient plasma membrane targeting of GFP-PI4KIIIÎ± requires co-overexpression of both EFR3 and TTC7. However, while overexpression of EFR3 increases the recovery of GFP-PI4KIIIÎ± in anti-TMEM150A-GFP immunoprecipitates (see below in Fig<xref ref-type="fig" rid="fig03">3C</xref>), a small pool of GFP-PI4KIIIÎ± is recovered in such immunoprecipitates also when only endogenous EFR3 is present or even after EFR3 (EFR3A and EFR3B) knockdown (Fig<xref ref-type="fig" rid="fig03">3B</xref>). Conversely, siRNA-mediated knockdown of TMEM150A did not change the subcellular localization pattern of PI4KIIIÎ±, EFR3B, and TTC7B when each of these proteins was overexpressed alone or in various combinations (Supplementary <xref ref-type="supplementary-material" rid="sd1">Fig S3</xref>).</p>
        <fig id="fig03" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Interplay between TMEM150A and components of the PI4KIIIÎ± complex
<list list-type="simple"><list-item><p>A Confocal imaging for GFP and mCherry fluorescence of live HeLa cells transfected with GFP-PI4KIIIÎ±, TMEM150A-mCherry, EFR3B-HA, and TTC7B-FLAG in various combinations. Scale bars: 20Â Î¼m.</p></list-item><list-item><p>B Western blot analysis for the epitopes and proteins indicated, of starting lysates and anti-GFP immunoprecipitates generated from HeLa cells treated with control or EFR3 (EFR3A and EFR3B)-specific siRNAs 24Â h prior to transfection of 3Â ÃÂ FLAG-PI4KIIIÎ± and TMEM150A-GFP as shown at the top.</p></list-item><list-item><p>C Western blot analysis for the epitopes and proteins indicated, of starting lysates and anti-GFP immunoprecipitates generated from HeLa cells transfected with 3Â ÃÂ FLAG-PI4KIIIÎ±, EFR3B-HA, TTC7B-mCherry, and TMEM150A-GFP as shown at the top.</p></list-item><list-item><p>D Western blot analysis for the epitopes and protein indicated, of starting lysates and anti-GFP immunoprecipitates generated from HeLa cells treated with control and PI4KIIIÎ±-specific siRNA 24Â h prior to transfection of EFR3B-HA and TMEM150A-GFP as shown at the top.</p></list-item></list></p>
          </caption>
          <graphic xlink:href="embr0016-0312-f3"/>
        </fig>
      </sec>
      <sec>
        <title>Overexpression of TMEM150A affects the interactions of TTC7 with EFR3 and PI4KIIIÎ±</title>
        <p>As our data support a link of TMEM150A to PI4KIIIÎ±, we explored whether TMEM150A interacts with EFR3 and TTC7 using biochemical experiments. HeLa cells were transiently transfected withÂ 3Â ÃÂ FLAG-PI4KIIIÎ±, EFR3B-HA, TTC7B-mCherry, and either TMEM150A-GFP or GFP. Extracts prepared from these cells were then immunoprecipitated with anti-GFP antibodies. Western blotting of immunoprecipitates from TMEM150A-GFP-expressing cells, but not of those from GFP-expressing cells, revealed robust presence of both PI4KIIIÎ± and EFR3, but surprisingly, not of TTC7B (Fig<xref ref-type="fig" rid="fig03">3C</xref>), suggesting the occurence of a complex between TMEM150A, PI4KIIIÎ±, and EFR3B that is distinct from the previously reported PI4KIIIÎ±/EFR3B/TTC7B complex <xref rid="b11" ref-type="bibr">11</xref>, <xref rid="b12" ref-type="bibr">12</xref>, <xref rid="b20" ref-type="bibr">20</xref>. Notably, when using cells expressing only TMEM150A-GFP and EFR3B-HA, a robust recovery of EFR3B-HA in TMEM150A-GFP immunoprecipitates, which was not affected by the siRNA-mediated knockdown of PI4KIIIÎ±, was observed, revealing an interaction of these two plasma membrane-localized proteins (Fig<xref ref-type="fig" rid="fig03">3D</xref>). Lack of dependence of the TMEM150A-EFR3 interaction on the presence of PI4KIIIÎ± was not unexpected because TTC7 is known to function as a bridge between PI4KIIIÎ± and EFR3 <xref rid="b11" ref-type="bibr">11</xref>, <xref rid="b20" ref-type="bibr">20</xref>, and the PI4KIIIÎ±/EFR3B/TMEM150A-GFP complex does not include TTC7.</p>
        <p>We further explored the surprising absence of TTC7 in PI4KIIIÎ±-EFR3B-TMEM150A complexes, as TTC7 overexpression was needed to target efficiently PI4KIIIÎ± to the plasma membrane under all conditions. As previously described, TTC7B-mCherry has a diffuse cytosolic localization when expressed alone <xref rid="b11" ref-type="bibr">11</xref>, but is recruited to the plasma membrane when co-expressed with EFR3, its direct and plasma membrane-localized interactor <xref rid="b11" ref-type="bibr">11</xref> (Fig<xref ref-type="fig" rid="fig04">4A</xref> and B). However, the additional expression of TMEM150A-GFP in cells co-expressing TTC7B-mCherry and EFR3 abolished the plasma membrane localization of TTC7B (Fig<xref ref-type="fig" rid="fig04">4C</xref>). Thus, the interaction of EFR3 with either TTC7 or with TMEM150A appears to be mutually exclusive. We corroborated this microscopic finding with biochemical experiments. In cells transfected with TMEM150A-GFP, EFR3B-HA, and TTC7B-FLAG, analysis of anti-EFR3B (anti-HA) and anti-TTC7B (anti-FLAG) immunoprecipitates revealed that TTC7B did not co-immunoprecipitate with EFR3B (Fig<xref ref-type="fig" rid="fig04">4D</xref>, top panel, compare lanes 9 and 10). Vice versa, EFR3B did not coimmunoprecipitate with TTC7B (Fig<xref ref-type="fig" rid="fig04">4D</xref>, bottom panel, compare lanes 8 and 10), if TMEM150A-GFP was also present. The appearance of a TTC7 fragment in cells overexpressing TMEM150A (Fig<xref ref-type="fig" rid="fig04">4D</xref>, asterisk) may reflect an impact of TMEM150A on TTC7 stability.</p>
        <fig id="fig04" position="float">
          <label>Figure 4</label>
          <caption>
            <p>The interaction of the EFR3-PI4KIIIÎ± complex with TMEM150A is mutually exclusive with the interaction with TTC7
<list list-type="simple"><list-item><p>A-C Confocal imaging of live HeLa cells transfected with TTC7B-mCherry alone or with EFR3B-HA and TMEM150A-GFP as indicated. Only the fluorescence of TTC7B-mCherry is shown. Scale bars: 20Â Î¼m.</p></list-item><list-item><p>D Anti-HA and anti-FLAG Western blots of starting lysates and immunoprecipitates generated from lysates of HeLa cells triple-transfected with EFR3B-HA, TTC7B-FLAG, and TMEM150A-GFP. Protein complexes were immunoprecipitated by anti-HA (top panels) or anti-FLAG (bottom panels) antibodies. The asterisk indicates fragments of TTC7B just below the full-length TTC7B bands.</p></list-item><list-item><p>E Western blot analysis for the epitopes and proteins indicated, of starting lysates and anti-GFP immunoprecipitates generated from HeLa cells transfected with 3Â ÃÂ FLAG-PI4KIIIÎ±, EFR3B-HA, TMEM150A-mCherry, and TTC7B-GFP as shown at the top.</p></list-item></list></p>
          </caption>
          <graphic xlink:href="embr0016-0312-f4"/>
        </fig>
        <p>We also assessed more directly if TTC7 is only present in complexes that exclude TMEM150A in HeLa cells overexpression expressing various combinations of the four proteins (PI4KIIIÎ±, EFR3, TMEM150A, and TTC7B), using TTC7-GFP as a bait in immunoprecipitation experiments. Both EFR3B and PI4KIIIÎ± were recovered in the immunoprecipitates in the absence of TMEM150A overexpression (Fig<xref ref-type="fig" rid="fig04">4E</xref>, lane 5), but no EFR3B was recovered and the recovery of PI4KIIIÎ± was strongly reduced when TMEM150A was overexpressed (Fig<xref ref-type="fig" rid="fig04">4E</xref>, lane 6).</p>
        <p>Collectively, these results demonstrate that the interaction of EFR3 with TMEM150A is mutually exclusive with the interaction of TTC7 with EFR3 and that EFR3 and TMEM150A form a complex at the plasma membrane that does not include TTC7. Concerning PI4KIIIÎ±, its recruitment and concentration in the plasma membrane is critically dependent on TTC7 expression even if the bulk of TTC7 is cytosolic in the presence of TMEM150A. We hypothesize that a complex of PI4KIIIÎ± comprising TTC7 may represent an intermediate needed for the targeting/presentation of PI4KIIIÎ± to plasma membrane. At this membrane, the EFR3-TTC7 interaction is competed by the EFR3-TMEM150A interaction, which in turn leads to a stabilization of the plasma membrane localization of PI4KIIIÎ± even in the absence of TTC7, indicating that also the TTC7âPI4KIIIÎ± is lost.</p>
      </sec>
      <sec>
        <title>TMEM150A affects the resynthesis of PI(4,5)P<sub>2</sub> at the plasma membrane following its acute depletion</title>
        <p>If TMEM150A plays a role in anchoring PI4KIIIÎ± at the plasma membrane, one may expect its presence to have an impact of PI4P production in this membrane. In yeast, deletion of Sfk1 increases the severity of PI4P and PI(4,5)P<sub>2</sub> defects in a temperature-sensitive <italic>STT4</italic> mutant background <xref rid="b21" ref-type="bibr">21</xref>. To determine whether TMEM150A has a regulatory role in the metabolism of PI4P and its downstream metabolite PI(4,5)P<sub>2</sub> in mammalian cells, we first examined whether modulation of TMEM150A levels, via either overexpression or down-regulation through RNA interference, affects total levels of these phosphoinositides. As quantified by HPLC, no significant differences in the total levels of PI4P and PI(4,5)P<sub>2</sub> were observed in TMEM150A-overexpressing or knockdown cells (Supplementary <xref ref-type="supplementary-material" rid="sd1">Fig S4</xref>), although a modest decrease in the level of plasma membrane-associated PI4P, as detected by an immunofluorescence staining procedure <xref rid="b15" ref-type="bibr">15</xref>, <xref rid="b24" ref-type="bibr">24</xref>, <xref rid="b25" ref-type="bibr">25</xref>, was observed in the TMEM150A knockdown cells (Supplementary <xref ref-type="supplementary-material" rid="sd1">Fig S5</xref>). This result prompted us to investigate whether an effect of TMEM150A overexpression or knockdown on phosphoinositide metabolism could be revealed by monitoring the response to an acute perturbation. To this aim, we examined the efficiency of PI(4,5)P<sub>2</sub> resynthesis after triggered PLC-mediated hydrolysis.</p>
        <p>In cells transiently transfected with the M1 muscarinic acetylcholine receptor (M1R), stimulation with the agonist oxotremorine-M (Oxo-M) results in phospholipase C (PLC) activation, leading to the rapid and massive cleavage of plasma membrane PI(4,5)P<sub>2</sub> into IP<sub>3</sub> and DAG <xref rid="b26" ref-type="bibr">26</xref>. Subsequent application of the M1R antagonist atropine terminates PLC activation, allowing the cell to resynthesize PI(4,5)P<sub>2</sub> from PI4P at the plasma membrane. Importantly, it hasÂ been well established that PI(4,5)P<sub>2</sub> resynthesis under these conditions requires PI4P generation by PI4KIIIÎ± <xref rid="b13" ref-type="bibr">13</xref>, <xref rid="b15" ref-type="bibr">15</xref>, <xref rid="b25" ref-type="bibr">25</xref>, <xref rid="b27" ref-type="bibr">27</xref>, <xref rid="b28" ref-type="bibr">28</xref>, <xref rid="b29" ref-type="bibr">29</xref>. We used this model and monitored PI(4,5)P<sub>2</sub> changes in the plasma membrane by examining the fluorescence of GFP-PH<sub>PLCÎ´</sub>, a genetically encoded PI(4,5)P<sub>2</sub> marker, using total internal reflection fluorescence (TIRF) microscopy <xref rid="b26" ref-type="bibr">26</xref>, <xref rid="b30" ref-type="bibr">30</xref> (Fig<xref ref-type="fig" rid="fig05">5A</xref>).</p>
        <fig id="fig05" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Levels of TMEM150A affect the rate of PI(4,5)P<sub>2</sub> resynthesis at the plasma membrane
<list list-type="simple"><list-item><p>A Time course of GFP fluorescence, as assessed by TIRF microscopy, from HeLa cells transfected with GFP-PH<sub>PLC</sub><sub>Î´</sub> and muscarinic receptor (M1R) and pretreated with compound A1 (100Â nM) for 10Â min. Oxo-M (10Â mM) and atropine (50Â mM) were added at the indicated times. Kymographs of representative cells (top) and normalized average traces (bottom; <italic>n</italic>Â â¥Â 10) are shown. Quantitative data are represented as meanÂ Â±Â SEM.</p></list-item><list-item><p>B Time course of GFP fluorescence as in (A) from HeLa cells expressing the indicated proteins together with GFP-PH<sub>PLC</sub><sub>Î´</sub> and M1R.</p></list-item><list-item><p>C Bar graph showing initial rate of PI(4,5)P<sub>2</sub> recovery (before atropine) from (B), represented as meanÂ Â±Â SEM (<italic>n</italic>Â â¥Â 10). Statistical significance was assessed by Student's <italic>t</italic>-test. ****<italic>P</italic>Â &lt;Â 0.0001.</p></list-item><list-item><p>D Time course of normalized GFP fluorescence, as in (A) from HeLa cells expressing the indicated proteins together with GFP-PH<sub>PLC</sub><sub>Î´</sub> and M1R, and in addition treated with control TMEM150A-specific siRNA 24Â h prior to other transfection.</p></list-item><list-item><p>E Bar graph showing initial rate of PI(4,5)P<sub>2</sub> recovery (after atropine) from (D), represented as meanÂ Â±Â SEM (<italic>n</italic>Â â¥Â 10). Statistical significance was assessed by Student's <italic>t</italic>-test. ****<italic>P</italic>Â &lt;Â 0.0001.</p></list-item><list-item><p>F Schematic representation of PI4KIIIÎ± interactions at the plasma membrane. TTC7 interacts directly with both PI4KIIIÎ± and EFR3. The presence of TMEM150A in a complex comprising PI4KIIIÎ± is mutually exclusive to the presence in the complex of TTC7. The interactions of TMEM150A shown at the right were demonstrated biochemically and result in a positive regulation of PI4KIIIÎ± but may be indirect.</p></list-item></list></p>
          </caption>
          <graphic xlink:href="embr0016-0312-f5"/>
        </fig>
        <p>In pilot experiments, we confirmed the requirement of PI4KIIIÎ± for PI(4,5)P<sub>2</sub> resynthesis, as this recovery was completely blockedÂ by a very potent and highly specific PI4KIIIÎ± inhibitor, the compound A1 <xref rid="b15" ref-type="bibr">15</xref> (Fig<xref ref-type="fig" rid="fig05">5A</xref>). Transient expression of TMEM150A accelerated PI(4,5)P<sub>2</sub> recovery (Fig<xref ref-type="fig" rid="fig05">5B</xref>), with an initial rate of PI(4,5)P<sub>2</sub> recovery about 150% higher than that of control cells (Fig<xref ref-type="fig" rid="fig05">5C</xref>). A similar effect was observed with the transient expression of the TMEM150 Chimera (Fig<xref ref-type="fig" rid="fig05">5B</xref>), supporting the critical importance of the C-terminal region of TMEM150A, that is, its PI4KIIIÎ± binding region, in this effect. Conversely, knockdown of TMEM150A resulted in a reduction of the initial recovery rate of PI(4,5)P<sub>2</sub> levels, and the reduction was ârescuedâ by co-expression of wild-type TMEM150A or the TMEM150 Chimera (Fig<xref ref-type="fig" rid="fig05">5D</xref> and E).</p>
      </sec>
      <sec>
        <title>Concluding remarks</title>
        <p>Collectively, our study corroborates evidence for an important role of an integral membrane protein conserved from yeast to humans, Sfk1/TMEM150A, in the function of PI4KIIIÎ± to the plasma membrane. The occurence of a complex comprising PI4KIIIÎ± and TTC7 that binds EFR3 is strongly supported by genetic, biochemical, and structural data <xref rid="b11" ref-type="bibr">11</xref>, <xref rid="b12" ref-type="bibr">12</xref>, <xref rid="b20" ref-type="bibr">20</xref>. Our present findings support a critical role of TTC7 together with EFR3 in the targeting of PI4KIIIÎ± to the plasma membrane. However, they also indicate that accumulation of TTC7 at the plasma membrane along with EFR3 and PI4KIIIÎ± is under the control of TMEM150A, as TMEM150A overexpression prevents such accumulation. We suggest the occurrence of two separate PI4KIIIÎ±-containing complexes: (1) a complex comprising PI4KIIIÎ±, EFR3, and TTC7, which is required for initial targeting of PI4KIIIÎ± to the plasma membrane and predominates in the absence of overexpressed TMEM150A; (2) another complex only in the plasma membrane that comprises PI4KIIIÎ±, EFR3, and TMEM150A, but that excludes TTC7 and predominates when TMEM150A is overexpressed. Additional work is required to test this hypothesis. It is also possible that levels of TMEM150A may control interactions of TTC7 indirectly. Collectively, however, our data clearly reveal a plasticity of the PI4KIIIÎ± complex. The mechanisms underlying this plasticity remain unknown.</p>
        <p>Additionally, our data show that the presence of TMEM150A positively regulates PI4P production. As members of the Sfk1/TMEM150A comprise a highly conserved region containing six predicted transmembrane spans, they are unlikely to act simply as membrane-anchoring factors for Stt4/PI4KIIIÎ± and may affect PI4KIIIÎ± function both directly and indirectly. The expression of five TMEM150 family members with different localization and properties in mammalian cells further supports this possibility. Addressing these properties and their potential impact on the dynamics of PI4P is an important priority for future work in this field.</p>
      </sec>
    </sec>
    <sec sec-type="materials|methods">
      <title>Materials and Methods</title>
      <sec>
        <title>Cell extracts, immunoprecipitation, and immunoblotting</title>
        <p>For immunoprecipitation, cell lysates were incubated with Chromotek GFP-trap agarose beads (Allele Biotech), anti-HA affinity matrix (Roche), or anti-FLAG M2 affinity gel (Sigma-Aldrich), and the solubilized bead-bound material was processed for SDSâPAGE and standard procedure of immunoblotting. Further details are described in the Supplementary Information.</p>
      </sec>
      <sec>
        <title>Antibody accessibility assay</title>
        <p>Briefly, to detect cell surface epitopes, HeLa cells transfected with proper constructs were cooled to 4Â°C and incubated with primary antibodies without fixation at 4Â°C (non-permeabilized conditions). Cells were then fixed with 4% paraformaldehyde/PBS. Further details are described in the Supplementary Information.</p>
      </sec>
      <sec>
        <title>Immunostaining for the plasma membrane PI(4)P</title>
        <p>Immunostaining of the plasma membrane PI(4)P was performed and quantified as described in the reference paper <xref rid="b16" ref-type="bibr">16</xref>. Further details are described in the Supplementary Information.</p>
        <p>Other methods are described in the Supplementary Information.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <p>We would like to thank Michael Caplan and Christopher Burd for helpful discussions and Louise Lucast for help with lipid analysis. This work was supported in part by grants from the NIH (R37NS036251, DK082700, and DA018343 to PDC; T32GM007223 to JC; and K99GM110121 to JMB) and from the Simons Foundation to PDC and from a fellowship from the Jane Coffin Childs Fund to JMB.</p>
    </ack>
    <sec>
      <title>Author contributions</title>
      <p>JC, FN, JB, and PDC designed the experiments; JC performed the experiments; all authors contributed to writing the manuscript.</p>
    </sec>
    <sec>
      <title>Conflict of interest</title>
      <p>The authors declare that they have no conflict of interest.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="b1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Di Paolo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>De Camilli</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Phosphoinositides in cell regulation and membrane dynamics</article-title>
          <source>Nature</source>
          <year>2006</year>
          <volume>443</volume>
          <fpage>651</fpage>
          <lpage>657</lpage>
          <pub-id pub-id-type="pmid">17035995</pub-id>
        </element-citation>
      </ref>
      <ref id="b2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Balla</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Phosphoinositides: tiny lipids with giant impact on cell regulation</article-title>
          <source>Physiol Rev</source>
          <year>2013</year>
          <volume>93</volume>
          <fpage>1019</fpage>
          <lpage>1137</lpage>
          <pub-id pub-id-type="pmid">23899561</pub-id>
        </element-citation>
      </ref>
      <ref id="b3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D'Angelo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vicinanza</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Di Campli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>De Matteis</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>The multiple roles of PtdIns(4)P - not just the precursor of PtdIns(4,5)P2</article-title>
          <source>J Cell Sci</source>
          <year>2008</year>
          <volume>121</volume>
          <fpage>1955</fpage>
          <lpage>1963</lpage>
          <pub-id pub-id-type="pmid">18525025</pub-id>
        </element-citation>
      </ref>
      <ref id="b4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berridge</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Irvine</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>Inositol phosphates and cell signalling</article-title>
          <source>Nature</source>
          <year>1989</year>
          <volume>341</volume>
          <fpage>197</fpage>
          <lpage>205</lpage>
          <pub-id pub-id-type="pmid">2550825</pub-id>
        </element-citation>
      </ref>
      <ref id="b5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lehto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Laitinen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chinetti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Johansson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ehnholm</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Staels</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ikonen</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Olkkonen</surname>
              <given-names>VM</given-names>
            </name>
          </person-group>
          <article-title>The OSBP-related protein family in humans</article-title>
          <source>J Lipid Res</source>
          <year>2001</year>
          <volume>42</volume>
          <fpage>1203</fpage>
          <lpage>1213</lpage>
          <pub-id pub-id-type="pmid">11483621</pub-id>
        </element-citation>
      </ref>
      <ref id="b6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raychaudhuri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Prinz</surname>
              <given-names>WA</given-names>
            </name>
          </person-group>
          <article-title>The diverse functions of oxysterol-binding proteins</article-title>
          <source>Annu Rev Cell Dev Biol</source>
          <year>2010</year>
          <volume>26</volume>
          <fpage>157</fpage>
          <lpage>177</lpage>
          <pub-id pub-id-type="pmid">19575662</pub-id>
        </element-citation>
      </ref>
      <ref id="b7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Saint-Jean</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Delfosse</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Douguet</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Chicanne</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Payrastre</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bourguet</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Antonny</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Drin</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Osh4p exchanges sterols for phosphatidylinositol 4-phosphate between lipid bilayers</article-title>
          <source>J Cell Biol</source>
          <year>2011</year>
          <volume>195</volume>
          <fpage>965</fpage>
          <lpage>978</lpage>
          <pub-id pub-id-type="pmid">22162133</pub-id>
        </element-citation>
      </ref>
      <ref id="b8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mesmin</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bigay</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Moser von Filseck</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lacas-Gervais</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Drin</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Antonny</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>A four-step cycle driven by PI(4)P hydrolysis directsÂ sterol/PI(4)P exchange by the ER-Golgi tether OSBP</article-title>
          <source>Cell</source>
          <year>2013</year>
          <volume>155</volume>
          <fpage>830</fpage>
          <lpage>843</lpage>
          <pub-id pub-id-type="pmid">24209621</pub-id>
        </element-citation>
      </ref>
      <ref id="b9">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trotter</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>WI</given-names>
            </name>
            <name>
              <surname>Pedretti</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yates</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Voelker</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
          <article-title>A genetic screen for aminophospholipid transport mutants identifies the phosphatidylinositol 4-kinase, STT4p, as an essential component in phosphatidylserine metabolism</article-title>
          <source>J Biol Chem</source>
          <year>1998</year>
          <volume>273</volume>
          <fpage>13189</fpage>
          <lpage>13196</lpage>
          <pub-id pub-id-type="pmid">9582361</pub-id>
        </element-citation>
      </ref>
      <ref id="b10">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tabuchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Audhya</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Parsons</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Boone</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Emr</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
          <article-title>The phosphatidylinositol 4,5-biphosphate and TORC2 binding proteins Slm1 and Slm2 function in sphingolipid regulation</article-title>
          <source>Mol Cell Biol</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>5861</fpage>
          <lpage>5875</lpage>
          <pub-id pub-id-type="pmid">16847337</pub-id>
        </element-citation>
      </ref>
      <ref id="b11">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakatsu</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Baskin</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tanner</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Shui</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Pirruccello</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hao</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ingolia</surname>
              <given-names>NT</given-names>
            </name>
            <name>
              <surname>Wenk</surname>
              <given-names>MR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PtdIns4P synthesis by PI4KIIIÎ± at the plasma membrane and its impact on plasma membrane identity</article-title>
          <source>J Cell Biol</source>
          <year>2012</year>
          <volume>199</volume>
          <fpage>1003</fpage>
          <lpage>1016</lpage>
          <pub-id pub-id-type="pmid">23229899</pub-id>
        </element-citation>
      </ref>
      <ref id="b12">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baird</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Stefan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Audhya</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Weys</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Emr</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
          <article-title>Assembly of the PtdIns 4-kinase Stt4 complex at the plasma membrane requires Ypp1 and Efr3</article-title>
          <source>J Cell Biol</source>
          <year>2008</year>
          <volume>183</volume>
          <fpage>1061</fpage>
          <lpage>1074</lpage>
          <pub-id pub-id-type="pmid">19075114</pub-id>
        </element-citation>
      </ref>
      <ref id="b13">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Balla</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>A plasma membrane pool of phosphatidylinositol 4-phosphate is generated by phosphatidylinositol 4-kinase type-III alpha: studies with the PH domains of the oxysterol binding protein and FAPP1</article-title>
          <source>Mol Biol Cell</source>
          <year>2005</year>
          <volume>16</volume>
          <fpage>1282</fpage>
          <lpage>1295</lpage>
          <pub-id pub-id-type="pmid">15635101</pub-id>
        </element-citation>
      </ref>
      <ref id="b14">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Audhya</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Foti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Emr</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
          <article-title>Distinct roles for the yeast phosphatidylinositol 4-kinases, Stt4p and Pik1p, in secretion, cell growth, and organelle membrane dynamics</article-title>
          <source>Mol Biol Cell</source>
          <year>2000</year>
          <volume>11</volume>
          <fpage>2673</fpage>
          <lpage>2689</lpage>
          <pub-id pub-id-type="pmid">10930462</pub-id>
        </element-citation>
      </ref>
      <ref id="b15">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bojjireddy</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Botyanszki</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hammond</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Creech</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kemp</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Snead</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Morrison</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pharmacological and genetic targeting of the PI4KA enzyme reveals its important role in maintaining plasma membrane phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate levels</article-title>
          <source>J Biol Chem</source>
          <year>2014</year>
          <volume>289</volume>
          <fpage>6120</fpage>
          <lpage>6132</lpage>
          <pub-id pub-id-type="pmid">24415756</pub-id>
        </element-citation>
      </ref>
      <ref id="b16">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vaillancourt</surname>
              <given-names>FH</given-names>
            </name>
            <name>
              <surname>Brault</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pilote</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Uyttersprot</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Gaillard</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Stoltz</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Knight</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Pantages</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>McFarland</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Breitfelder</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evaluation of phosphatidylinositol-4-kinase IIIÎ± as a hepatitis C virus drug target</article-title>
          <source>J Virol</source>
          <year>2012</year>
          <volume>86</volume>
          <fpage>11595</fpage>
          <lpage>11607</lpage>
          <pub-id pub-id-type="pmid">22896614</pub-id>
        </element-citation>
      </ref>
      <ref id="b17">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berger</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Kelly</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Jordan</surname>
              <given-names>TX</given-names>
            </name>
            <name>
              <surname>Tartell</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Randall</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Hepatitis C virus stimulates the phosphatidylinositol 4-kinase III alpha-dependent phosphatidylinositol 4-phosphate production that is essential for its replication</article-title>
          <source>J Virol</source>
          <year>2011</year>
          <volume>85</volume>
          <fpage>8870</fpage>
          <lpage>8883</lpage>
          <pub-id pub-id-type="pmid">21697487</pub-id>
        </element-citation>
      </ref>
      <ref id="b18">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reiss</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rebhan</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Backes</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Romero-Brey</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Erfle</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Matula</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kaderali</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Poenisch</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Blankenburg</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hiet</surname>
              <given-names>M-S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment</article-title>
          <source>Cell Host Microbe</source>
          <year>2011</year>
          <volume>9</volume>
          <fpage>32</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">21238945</pub-id>
        </element-citation>
      </ref>
      <ref id="b19">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borawski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Troke</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Puyang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Gibaja</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mickanin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Leighton-Davies</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Myer</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>CornellaTaracido</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication</article-title>
          <source>J Virol</source>
          <year>2009</year>
          <volume>83</volume>
          <fpage>10058</fpage>
          <lpage>10074</lpage>
          <pub-id pub-id-type="pmid">19605471</pub-id>
        </element-citation>
      </ref>
      <ref id="b20">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Chi</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Baskin</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Lucast</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Burd</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>De Camilli</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Reinisch</surname>
              <given-names>KM</given-names>
            </name>
          </person-group>
          <article-title>Structural insights into assembly and regulation of the plasmaÂ membrane phosphatidylinositol 4-kinase complex</article-title>
          <source>Dev Cell</source>
          <year>2014</year>
          <volume>28</volume>
          <fpage>19</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="pmid">24360784</pub-id>
        </element-citation>
      </ref>
      <ref id="b21">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Audhya</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Emr</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Stt4 PI 4-kinase localizes to the plasma membrane and functions in the Pkc1-mediated MAP kinase cascade</article-title>
          <source>Dev Cell</source>
          <year>2002</year>
          <volume>2</volume>
          <fpage>593</fpage>
          <lpage>605</lpage>
          <pub-id pub-id-type="pmid">12015967</pub-id>
        </element-citation>
      </ref>
      <ref id="b22">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crighton</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wilkinson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>O'Prey</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Syed</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Gasco</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Garrone</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Crook</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ryan</surname>
              <given-names>KM</given-names>
            </name>
          </person-group>
          <article-title>DRAM, a p53-induced modulator of autophagy, is critical for apoptosis</article-title>
          <source>Cell</source>
          <year>2006</year>
          <volume>126</volume>
          <fpage>121</fpage>
          <lpage>134</lpage>
          <pub-id pub-id-type="pmid">16839881</pub-id>
        </element-citation>
      </ref>
      <ref id="b23">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>S-M</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>E-J</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>B-K</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Seo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Jang</surname>
              <given-names>I-S</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>S-H</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J-H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Reduced expression of DRAM2/TMEM77 in tumor cells interferes with cell death</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2009</year>
          <volume>390</volume>
          <fpage>1340</fpage>
          <lpage>1344</lpage>
          <pub-id pub-id-type="pmid">19895784</pub-id>
        </element-citation>
      </ref>
      <ref id="b24">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hammond</surname>
              <given-names>GRV</given-names>
            </name>
            <name>
              <surname>Schiavo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Irvine</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>Immunocytochemical techniques reveal multiple, distinct cellular pools of PtdIns4P and PtdIns(4,5)P(2)</article-title>
          <source>Biochem J</source>
          <year>2009</year>
          <volume>422</volume>
          <fpage>23</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="pmid">19508231</pub-id>
        </element-citation>
      </ref>
      <ref id="b25">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hammond</surname>
              <given-names>GRV</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Holdich</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Koteci</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Balla</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Irvine</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>PI4P and PI(4,5)P2 are essential but independent lipid determinants of membrane identity</article-title>
          <source>Science</source>
          <year>2012</year>
          <volume>337</volume>
          <fpage>727</fpage>
          <lpage>730</lpage>
          <pub-id pub-id-type="pmid">22722250</pub-id>
        </element-citation>
      </ref>
      <ref id="b26">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Falkenburger</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Hille</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Kinetics of M1 muscarinic receptor and G protein signaling to phospholipase C in living cells</article-title>
          <source>J Gen Physiol</source>
          <year>2010</year>
          <volume>135</volume>
          <fpage>81</fpage>
          <lpage>97</lpage>
          <pub-id pub-id-type="pmid">20100890</pub-id>
        </element-citation>
      </ref>
      <ref id="b27">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horowitz</surname>
              <given-names>LF</given-names>
            </name>
          </person-group>
          <article-title>Phospholipase C in living cells: activation, inhibition, Ca<sup>2+</sup> requirement, and regulation of M current</article-title>
          <source>J Gen Physiol</source>
          <year>2005</year>
          <volume>126</volume>
          <fpage>243</fpage>
          <lpage>262</lpage>
          <pub-id pub-id-type="pmid">16129772</pub-id>
        </element-citation>
      </ref>
      <ref id="b28">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Balla</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Varnai</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Szentpetery</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Knight</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Shokat</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Balla</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Maintenance of hormone-sensitive phosphoinositide pools in the plasma membrane requires phosphatidylinositol 4-kinase IIIalpha</article-title>
          <source>Mol Biol Cell</source>
          <year>2008</year>
          <volume>19</volume>
          <fpage>711</fpage>
          <lpage>721</lpage>
          <pub-id pub-id-type="pmid">18077555</pub-id>
        </element-citation>
      </ref>
      <ref id="b29">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dickson</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Hille</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Golgi and plasma membrane pools of PI(4)P contribute to plasma membrane PI(4,5)P2 and maintenance of KCNQ2/3 ion channel current</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2014</year>
          <volume>111</volume>
          <fpage>E2281</fpage>
          <lpage>E2290</lpage>
          <pub-id pub-id-type="pmid">24843134</pub-id>
        </element-citation>
      </ref>
      <ref id="b30">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lemmon</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Membrane recognition by phospholipid-binding domains</article-title>
          <source>Nat Rev Mol Cell Biol</source>
          <year>2008</year>
          <volume>9</volume>
          <fpage>99</fpage>
          <lpage>111</lpage>
          <pub-id pub-id-type="pmid">18216767</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec sec-type="supplementary-material">
      <title>Supporting Information</title>
      <supplementary-material content-type="local-data" id="sd1">
        <p>Supplementary Information</p>
        <media mimetype="pdf" mime-subtype="pdf" xlink:href="embr0016-0312-sd1.pdf" xlink:type="simple" id="d35e2041" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="sd2">
        <p>Review Process File</p>
        <media mimetype="pdf" mime-subtype="pdf" xlink:href="embr0016-0312-sd2.pdf" xlink:type="simple" id="d35e2045" position="anchor"/>
      </supplementary-material>
    </sec>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>